There has been a bit of discussion on the web about the recently published preliminary paper from the 3 year City of Hope Study instigated by Dr R Paul St Amand.
The paper, e-published ahead of print in Experimental biology and medicine, is by a group of researchers including Dr. R. Paul St. Amand, Claudia Craig Marek and Dr John (Jack) Shively PhD
As it says on the FibroAction website, “Dr. R. Paul St. Amand is the originator of the Guaifenesin Protocol for Fibromyalgia Syndrome (Fibro), a much debated treatment protocol that is not widely accepted by the medical community. Claudia Craig Marek, his medical assistant, is the author of ‘Fibromyalgia: The First Year’. The “City of Hope Fibromyalgia Study” is a three-year investigation involving patients of Dr St Amand, which is taking place at City of Hope Hospital in California, USA, where Dr Shively PhD is Chair of the Division of Immunology.”
The City of Hope study is looking for possible links with autoimmunity/inflammation and Fibro, as well as a genetic link. Many of the participants are on the Guaifenesin Protocol.
Part of the discussion online regarding the paper has centred on how incomprehensible the abstract is, even to someone with some medical knowledge. Having read and re-read the full paper and asked questions of both the lead researcher, Dr J Shively PhD, and advisors, I have written an article discussing the paper, which you can read here.
